These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 19569069)

  • 1. Metabolic syndrome increases mortality in heart failure.
    Tamariz L; Hassan B; Palacio A; Arcement L; Horswell R; Hebert K
    Clin Cardiol; 2009 Jun; 32(6):327-31. PubMed ID: 19569069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discharge treatment with angiotensin-converting enzyme inhibitor/angiotensin receptor blocker after a heart failure hospitalisation is associated with a better prognosis irrespective of left ventricular ejection fraction.
    Vicent L; Cinca J; Vazquez-García R; Gonzalez-Juanatey JR; Rivera M; Segovia J; Pascual-Figal D; Bover R; Worner F; Delgado-Jiménez J; Fernández-Avilés F; Martínez-Sellés M
    Intern Med J; 2019 Dec; 49(12):1505-1513. PubMed ID: 30887642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of a patient education programme in heart failure with preserved ejection fraction: Results from the ODIN cohort study using propensity score matching.
    Agrinier N; Schockmel M; Thilly N; Laborde-Castérot H; Jourdain P; Alla F; Leclercq C; Dany F; Druelle J; Drouet E; Mulak G; Juillière Y;
    Arch Cardiovasc Dis; 2018 Jan; 111(1):5-16. PubMed ID: 28943262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mode of death in patients with heart failure and reduced vs. preserved ejection fraction: report from the registry of hospitalized heart failure patients.
    Hamaguchi S; Kinugawa S; Sobirin MA; Goto D; Tsuchihashi-Makaya M; Yamada S; Yokoshiki H; Tsutsui H;
    Circ J; 2012; 76(7):1662-9. PubMed ID: 22481105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Metabolic Syndrome, Cardiovascular Fitness and Survival in Patients With Advanced Systolic Heart Failure.
    Vest AR; Young JB; Cho L
    Am J Cardiol; 2018 Nov; 122(9):1513-1519. PubMed ID: 30172361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary Artery Pressure-Guided Management of Patients With Heart Failure and Reduced Ejection Fraction.
    Givertz MM; Stevenson LW; Costanzo MR; Bourge RC; Bauman JG; Ginn G; Abraham WT;
    J Am Coll Cardiol; 2017 Oct; 70(15):1875-1886. PubMed ID: 28982501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of Ejection Fraction on Outcomes and Efficacy of Sacubitril/Valsartan (LCZ696) in Heart Failure with Reduced Ejection Fraction: The Prospective Comparison of ARNI with ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure (PARADIGM-HF) Trial.
    Solomon SD; Claggett B; Desai AS; Packer M; Zile M; Swedberg K; Rouleau JL; Shi VC; Starling RC; Kozan Ö; Dukat A; Lefkowitz MP; McMurray JJ
    Circ Heart Fail; 2016 Mar; 9(3):e002744. PubMed ID: 26915374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of indeterminable anaerobic threshold in heart failure.
    Agostoni P; Corrà U; Cattadori G; Veglia F; Battaia E; La Gioia R; Scardovi AB; Emdin M; Metra M; Sinagra G; Limongelli G; Raimondo R; Re F; Guazzi M; Belardinelli R; Parati G; Magrì D; Fiorentini C; Cicoira M; Salvioni E; Giovannardi M; Mezzani A; Scrutinio D; Di Lenarda A; Mantegazza V; Ricci R; Apostolo A; Iorio A; Paolillo S; Palermo P; Contini M; Vassanelli C; Passino C; Piepoli MF;
    Circ Heart Fail; 2013 Sep; 6(5):977-87. PubMed ID: 23881847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LV Mass as a Predictor of CVD Events in Older Adults With and Without Metabolic Syndrome and Diabetes.
    Hoang K; Zhao Y; Gardin JM; Carnethon M; Mukamal K; Yanez D; Wong ND
    JACC Cardiovasc Imaging; 2015 Sep; 8(9):1007-1015. PubMed ID: 26319502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low serum sodium as a poor prognostic indicator for mortality in congestive heart failure patients.
    DeWolfe A; Lopez B; Arcement LM; Hebert K
    Clin Cardiol; 2010 Dec; 33(12):E13-7. PubMed ID: 21184540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic impact of chronic obstructive pulmonary disease on adverse prognosis in hospitalized heart failure patients with preserved ejection fraction - A report from the JASPER registry.
    Sato Y; Yoshihisa A; Oikawa M; Nagai T; Yoshikawa T; Saito Y; Yamamoto K; Takeishi Y; Anzai T
    J Cardiol; 2019 Jun; 73(6):459-465. PubMed ID: 30718015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physical activity measured with implanted devices predicts patient outcome in chronic heart failure.
    Conraads VM; Spruit MA; Braunschweig F; Cowie MR; Tavazzi L; Borggrefe M; Hill MR; Jacobs S; Gerritse B; van Veldhuisen DJ
    Circ Heart Fail; 2014 Mar; 7(2):279-87. PubMed ID: 24519908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac Resynchronization Therapy Using Quadripolar Versus Non-Quadripolar Left Ventricular Leads Programmed to Biventricular Pacing With Single-Site Left Ventricular Pacing: Impact on Survival and Heart Failure Hospitalization.
    Leyva F; Zegard A; Qiu T; Acquaye E; Ferrante G; Walton J; Marshall H
    J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29042422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of ejection fraction on the prognostic value of sympathetic innervation imaging with iodine-123 MIBG in heart failure.
    Shah AM; Bourgoun M; Narula J; Jacobson AF; Solomon SD
    JACC Cardiovasc Imaging; 2012 Nov; 5(11):1139-46. PubMed ID: 23153914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary Vascular Distensibility Predicts Pulmonary Hypertension Severity, Exercise Capacity, and Survival in Heart Failure.
    Malhotra R; Dhakal BP; Eisman AS; Pappagianopoulos PP; Dress A; Weiner RB; Baggish AL; Semigran MJ; Lewis GD
    Circ Heart Fail; 2016 Jun; 9(6):. PubMed ID: 27301469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Hospitalization Burden and Post-Hospitalization Mortality Risk in Heart Failure With Preserved Ejection Fraction: Results From the I-PRESERVE Trial (Irbesartan in Heart Failure and Preserved Ejection Fraction).
    Carson PE; Anand IS; Win S; Rector T; Haass M; Lopez-Sendon J; Miller A; Teerlink JR; White M; McKelvie RS; Komajda M; Zile MR; McMurray JJ; Massie B
    JACC Heart Fail; 2015 Jun; 3(6):429-441. PubMed ID: 25982110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factor-based subphenotyping of heart failure in the community.
    Andersson C; Lyass A; Xanthakis V; Larson MG; Mitchell GF; Cheng S; Vasan RS
    PLoS One; 2019; 14(10):e0222886. PubMed ID: 31613888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statin therapy and mortality among patients hospitalized with heart failure and preserved left ventricular function--a preliminary report.
    Roik M; Starczewska MH; Huczek Z; Kochanowski J; Opolski G
    Acta Cardiol; 2008 Dec; 63(6):683-92. PubMed ID: 19157162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased heart failure risk in normal-weight people with metabolic syndrome compared with metabolically healthy obese individuals.
    Voulgari C; Tentolouris N; Dilaveris P; Tousoulis D; Katsilambros N; Stefanadis C
    J Am Coll Cardiol; 2011 Sep; 58(13):1343-50. PubMed ID: 21920263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heart Failure and Midrange Ejection Fraction: Implications of Recovered Ejection Fraction for Exercise Tolerance and Outcomes.
    Nadruz W; West E; Santos M; Skali H; Groarke JD; Forman DE; Shah AM
    Circ Heart Fail; 2016 Apr; 9(4):e002826. PubMed ID: 27009553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.